CDC Panel Backs mRNA COVID Vaccines Over J&J Due to Clot Risk

The CDC panel voted unanimously to prefer the Pfizer and Moderna vaccines following hearing a safety update on situations of thrombosis with thrombocytopenia syndrome, a problem that results in substantial clots that deplete the blood of platelets, ensuing in uncontrolled bleeding.